MeSH D006177 - gynecomastia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Tamoxifen | Tamoxifen |  | 2003-02-20 |  |  |
| Apotex | Tamoxifen | Tamoxifen |  | 2011-09-23 |  |  |
| AstraZeneca | Tamoxifen | Nolvadex |  | 1982-01-01 |  |  |
| Dr Reddys Laboratories | Tamoxifen | Tamoxifen |  | 2003-02-20 |  |  |
| Eugia Pharma Specialties | Tamoxifen | Tamoxifen |  | 2020-08-14 |  |  |
| Mayne Group | Tamoxifen | Soltamox |  | 2005-10-29 |  |  |
| Mylan | Tamoxifen | Tamoxifen |  | 2003-02-20 |  |  |
| Roxane Laboratories | Tamoxifen | Tamoxifen |  | 2003-02-20 |  |  |
| Teva | Tamoxifen | Tamoxifen |  | 2003-04-28 |  |  |
| Zydus Therapeutics | Tamoxifen | Tamoxifen |  | 2017-10-27 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
33%1/3
Phase 3
33%1/3
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use